IRB Committee 3 reviews all student-led human subjects research. Student-led protocols require a faculty sponsor; the faculty sponsor must ensure that IRB review/approval is obtained prior to research initiation. Specific IRB office hours, assistance, and training are available for students and/or their faculty sponsors.
IRB 3 does not review FDA-regulated research.
The IRB office has established office hours especially for students:
- Meet virtually or in person to ask questions about the IRB submission and review process
- Want to discuss human subjects' issues related to your specific project? Meet virtually on Tuesdays or in person on Thursdays!
- Receive guidance and answers to your specific questions in the drafting of your protocol before submitting it to the IRB
- Share your screen virtually or bring your laptop, and we’ll walk you through ICON
- Open office hours for students are from 9 am – 11:30 am virtually on Tuesdays via Zoom (see meeting information below) and Thursdays in person in room E. Cullen 403:
Attention Faculty Sponsors!
- Unsure of how to best review student IRB protocols prior to applying your approval signature?
Make an appointment to work with a compliance specialist to walk through the application and discuss what the IRB looks for in an application. A Faculty Sponsor Manual is also available to assist you in providing IRB-related guidance to your students.
- Will a student be engaged in your IRB-approved human subjects research for their thesis/dissertation? In many cases, if aims and instruments align, this student may be added to your approved protocol and does not have to have a protocol of their own. Contact the IRB office for additional information or to determine on a case-by-case basis.
|Submission Deadlines||IRB 3 Meeting Dates|
|Wednesday, July 19, 2023||Wednesday, August 2, 2023|
|Wednesday, August 23, 2023||Wednesday, September 13, 2023|
|Wednesday, September 20, 2023||Wednesday, October 04, 2023|
|Wednesday, October 18, 2023||Wednesday, November 01, 2023|
|Wednesday, November 15, 2023||Wednesday, December 06, 2023|
|Wednesday, December 13, 2023||Wednesday, January 10, 2024|
|Wednesday, January 24, 2024||Wednesday, February 07, 2024|
|Wednesday, February 21, 2024||Wednesday, March 06, 2024|
|Wednesday, March 20, 2024||Wednesday, April 03, 2024|
|Wednesday, April 17, 2024||Wednesday, May 01, 2024|
|Wednesday, May 22, 2024||Wednesday, June 05, 2024|
|Wednesday, June 19, 2024||Wednesday, July 10, 2024|
|Wednesday, July 24, 2024||Wednesday, August 07, 2024|
*Dates are subject to change without notice if circumstances require rescheduling.
Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 3 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approves or requires modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.
Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.